ADIAL PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
15 Contracts & Agreements
- At the Market Offering Agreement, dated April 18, 2024, by and between Adial Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on April 18, 2024)
- Final Acquisition Agreement, dated September 18, 2023, by and between Adovate LLC and Adial Pharmaceuticals, Inc (Filed With SEC on September 21, 2023)
- Option Exercise Agreement, dated May 8, 2023, by and between Adovate LLC and Adial Pharmaceuticals, Inc (Filed With SEC on May 10, 2023)
- Option Agreement for the Acquisition of Purnovate, Inc. by Adenomed, LLC dated as of January 27, 2023 (Filed With SEC on February 1, 2023)
- Lockup Agreement Extension executed Dr. Bankole Johnson, dated April 5, 2021 (Filed With SEC on April 9, 2021)
- Description of Securities (Filed With SEC on March 22, 2021)
- Offer Letter, dated December 14, 2020 (Filed With SEC on December 17, 2020)
- Lock-Up Agreement Extension and Right of First Refusal dated August 19, 2020 to Lock-Up Agreement (Filed With SEC on August 25, 2020)
- Description of Securities (Filed With SEC on March 20, 2020)
- Lock-Up Agreement, dated December 12, 2019 (Filed With SEC on December 16, 2019)
- Backstop Commitment Agreement between Adial Pharmaceuticals, Inc. and MVA 151 Investors LLC dated February 22, 2018 (Filed With SEC on April 16, 2018)
- UNDERWRITINGAGREEMENT between ADIALPHARMACEUTICALS, INC., and JOSEPHGUNNAR & CO., LLC asRepresentative of the Several Underwriters (Filed With SEC on November 22, 2017)
- Form of ADial Pharmaceuticals, LLC Option Agreement (Filed With SEC on September 7, 2017)
- Option Agreement between ADial Pharmaceuticals, LLC and Tony Goodman, effective July 1, 2017 (Filed With SEC on September 7, 2017)
- Form of Membership Unit Award (Profits Interest) Agreement (Filed With SEC on September 7, 2017)
